Stryker Inks $15M Settlement to Resolve Conformis Patent Dispute
“Conformis is a relatively small player in the orthopaedic market. Last year, with the pandemic dragging sales down, Conformis reported revenues of $68.8 million whereas net sales at Stryker clocked in at $14.4 billion. Stryker’s orthopaedic unit alone generated close to $5 billion in sales. Yet, Conformis has successfully pursued Zimmer and now Stryker over products it alleges infringe on its patents,” reports Nick Paul Taylor in Med Tech Dive.
“In 2015, Conformis granted Wright a license to use patient-specific instrument technology covered by its patents and patent applications with off-the-shelf foot and ankle implants. Five years later, in April 2020, Conformis filed a suit against Wright alleging products including Tornier Blueprint 3D Planning PSI shoulder replacement systems infringed on four of its patents.”
